Morocco’s Chamber of Counsellors has approved Bill 27-26, amending the country’s pharmaceutical code. The legislation aims to modernize national regulations governing medicines and pharmacies. A key objective is to enhance pharmaceutical safety standards across the nation. The bill also seeks to bolster Morocco’s health sovereignty by strengthening its domestic pharmaceutical sector. This move is intended to improve the overall healthcare landscape and ensure a more secure supply of medications. The updated code represents a significant step towards aligning Moroccan pharmaceutical practices with current international standards. It passed following previous approvals and is expected to be enacted soon.